Table of Contents
1 Report Overview
1.1 Research Scope
1.2 Top Testosterone Replacement Therapy Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Testosterone Replacement Therapy Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Gels
1.3.3 Injections
1.3.4 Patches
1.3.5 Other
1.4 Market Segment by Application
1.4.1 Global Testosterone Replacement Therapy Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Others
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Testosterone Replacement Therapy Revenue (2015-2026)
2.1.1 Global Testosterone Replacement Therapy Revenue (2015-2026)
2.1.2 Global Testosterone Replacement Therapy Sales (2015-2026)
2.2 Testosterone Replacement Therapy Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Testosterone Replacement Therapy Sales by Regions (2015-2020)
2.2.2 Global Testosterone Replacement Therapy Revenue by Regions (2015-2020)
2.3 Global Top Testosterone Replacement Therapy Regions (Countries) Ranking by Market Size
2.4 Testosterone Replacement Therapy Industry Trends
2.4.1 Testosterone Replacement Therapy Market Top Trends
2.4.2 Market Drivers
2.4.3 Testosterone Replacement Therapy Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Testosterone Replacement Therapy Players: Views for Future
3 Competitive Landscape by Manufacturers
3.1 Global Top Testosterone Replacement Therapy Manufacturers by Sales (2015-2020)
3.1.1 Global Testosterone Replacement Therapy Sales by Manufacturers (2015-2020)
3.1.2 Global Testosterone Replacement Therapy Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Testosterone Replacement Therapy Sales in 2019
3.2 Global Top Manufacturers Testosterone Replacement Therapy by Revenue
3.2.1 Global Testosterone Replacement Therapy Revenue by Manufacturers (2015-2020)
3.2.2 Global Testosterone Replacement Therapy Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Testosterone Replacement Therapy Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Testosterone Replacement Therapy as of 2019)
3.4 Global Testosterone Replacement Therapy Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Testosterone Replacement Therapy Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Testosterone Replacement Therapy Market
3.7 Key Manufacturers Testosterone Replacement Therapy Product Offered
3.8 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Testosterone Replacement Therapy Historic Market Review by Type (2015-2020)
4.1.2 Global Testosterone Replacement Therapy Sales Market Share by Type (2015-2020)
4.1.3 Global Testosterone Replacement Therapy Revenue Market Share by Type (2015-2020)
4.1.4 Testosterone Replacement Therapy Price by Type (2015-2020)
4.1 Global Testosterone Replacement Therapy Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Testosterone Replacement Therapy Sales Forecast by Type (2021-2026)
4.2.3 Global Testosterone Replacement Therapy Revenue Forecast by Type (2021-2026)
4.2.4 Testosterone Replacement Therapy Price Forecast by Type (2021-2026)
5 Global Testosterone Replacement Therapy Market Size by Application
5.1 Global Testosterone Replacement Therapy Historic Market Review by Application (2015-2020)
5.1.2 Global Testosterone Replacement Therapy Sales Market Share by Application (2015-2020)
5.1.3 Global Testosterone Replacement Therapy Revenue Market Share by Application (2015-2020)
5.1.4 Testosterone Replacement Therapy Price by Application (2015-2020)
5.2 Global Testosterone Replacement Therapy Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Testosterone Replacement Therapy Sales Forecast by Application (2021-2026)
5.2.3 Global Testosterone Replacement Therapy Revenue Forecast by Application (2021-2026)
5.2.4 Testosterone Replacement Therapy Price Forecast by Application (2021-2026)
6 North America
6.1 North America Testosterone Replacement Therapy Breakdown Data by Company
6.2 North America Testosterone Replacement Therapy Breakdown Data by Type
6.3 North America Testosterone Replacement Therapy Breakdown Data by Application
6.4 North America Testosterone Replacement Therapy Breakdown Data by Countries
6.4.1 North America Testosterone Replacement Therapy Sales by Countries
6.4.2 North America Testosterone Replacement Therapy Revenue by Countries
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Testosterone Replacement Therapy Breakdown Data by Company
7.2 Europe Testosterone Replacement Therapy Breakdown Data by Type
7.3 Europe Testosterone Replacement Therapy Breakdown Data by Application
7.4 Europe Testosterone Replacement Therapy Breakdown Data by Countries
7.4.1 Europe Testosterone Replacement Therapy Sales by Countries
7.4.2 Europe Testosterone Replacement Therapy Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
8 Asia Pacific
8.1 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Company
8.2 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Type
8.3 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Application
8.4 Asia Pacific Testosterone Replacement Therapy Breakdown Data by Regions
8.4.1 Asia Pacific Testosterone Replacement Therapy Sales by Regions
8.4.2 Asia Pacific Testosterone Replacement Therapy Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam
9 Latin America
9.1 Latin America Testosterone Replacement Therapy Breakdown Data by Company
9.2 Latin America Testosterone Replacement Therapy Breakdown Data by Type
9.3 Latin America Testosterone Replacement Therapy Breakdown Data by Application
9.4 Latin America Testosterone Replacement Therapy Breakdown Data by Countries
9.4.1 Latin America Testosterone Replacement Therapy Sales by Countries
9.4.2 Latin America Testosterone Replacement Therapy Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Testosterone Replacement Therapy Breakdown Data by Type
10.2 Middle East and Africa Testosterone Replacement Therapy Breakdown Data by Application
10.3 Middle East and Africa Testosterone Replacement Therapy Breakdown Data by Countries
10.3.1 Middle East and Africa Testosterone Replacement Therapy Sales by Countries
10.3.2 Middle East and Africa Testosterone Replacement Therapy Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E
11 Company Profiles
11.1 AbbVie
11.1.1 AbbVie Corporation Information
11.1.2 AbbVie Business Overview and Total Revenue (2019 VS 2018)
11.1.3 AbbVie Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 AbbVie Testosterone Replacement Therapy Products and Services
11.1.5 AbbVie SWOT Analysis
11.1.6 AbbVie Recent Developments
11.2 Endo International
11.2.1 Endo International Corporation Information
11.2.2 Endo International Business Overview and Total Revenue (2019 VS 2018)
11.2.3 Endo International Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.2.4 Endo International Testosterone Replacement Therapy Products and Services
11.2.5 Endo International SWOT Analysis
11.2.6 Endo International Recent Developments
11.3 Eli lilly
11.3.1 Eli lilly Corporation Information
11.3.2 Eli lilly Business Overview and Total Revenue (2019 VS 2018)
11.3.3 Eli lilly Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.3.4 Eli lilly Testosterone Replacement Therapy Products and Services
11.3.5 Eli lilly SWOT Analysis
11.3.6 Eli lilly Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Business Overview and Total Revenue (2019 VS 2018)
11.4.3 Pfizer Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.4.4 Pfizer Testosterone Replacement Therapy Products and Services
11.4.5 Pfizer SWOT Analysis
11.4.6 Pfizer Recent Developments
11.5 Actavis (Allergan)
11.5.1 Actavis (Allergan) Corporation Information
11.5.2 Actavis (Allergan) Business Overview and Total Revenue (2019 VS 2018)
11.5.3 Actavis (Allergan) Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.5.4 Actavis (Allergan) Testosterone Replacement Therapy Products and Services
11.5.5 Actavis (Allergan) SWOT Analysis
11.5.6 Actavis (Allergan) Recent Developments
11.6 Bayer
11.6.1 Bayer Corporation Information
11.6.2 Bayer Business Overview and Total Revenue (2019 VS 2018)
11.6.3 Bayer Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.6.4 Bayer Testosterone Replacement Therapy Products and Services
11.6.5 Bayer SWOT Analysis
11.6.6 Bayer Recent Developments
11.7 Novartis
11.7.1 Novartis Corporation Information
11.7.2 Novartis Business Overview and Total Revenue (2019 VS 2018)
11.7.3 Novartis Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.7.4 Novartis Testosterone Replacement Therapy Products and Services
11.7.5 Novartis SWOT Analysis
11.7.6 Novartis Recent Developments
11.8 Teva
11.8.1 Teva Corporation Information
11.8.2 Teva Business Overview and Total Revenue (2019 VS 2018)
11.8.3 Teva Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.8.4 Teva Testosterone Replacement Therapy Products and Services
11.8.5 Teva SWOT Analysis
11.8.6 Teva Recent Developments
11.9 Mylan
11.9.1 Mylan Corporation Information
11.9.2 Mylan Business Overview and Total Revenue (2019 VS 2018)
11.9.3 Mylan Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.9.4 Mylan Testosterone Replacement Therapy Products and Services
11.9.5 Mylan SWOT Analysis
11.9.6 Mylan Recent Developments
11.10 Upsher-Smith
11.10.1 Upsher-Smith Corporation Information
11.10.2 Upsher-Smith Business Overview and Total Revenue (2019 VS 2018)
11.10.3 Upsher-Smith Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.10.4 Upsher-Smith Testosterone Replacement Therapy Products and Services
11.10.5 Upsher-Smith SWOT Analysis
11.10.6 Upsher-Smith Recent Developments
11.11 Ferring Pharmaceuticals
11.11.1 Ferring Pharmaceuticals Corporation Information
11.11.2 Ferring Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.11.3 Ferring Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.11.4 Ferring Pharmaceuticals Testosterone Replacement Therapy Products and Services
11.11.5 Ferring Pharmaceuticals SWOT Analysis
11.11.6 Ferring Pharmaceuticals Recent Developments
11.12 Kyowa Kirin
11.12.1 Kyowa Kirin Corporation Information
11.12.2 Kyowa Kirin Business Overview and Total Revenue (2019 VS 2018)
11.12.3 Kyowa Kirin Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.12.4 Kyowa Kirin Testosterone Replacement Therapy Products and Services
11.12.5 Kyowa Kirin SWOT Analysis
11.12.6 Kyowa Kirin Recent Developments
11.13 Acerus Pharmaceuticals
11.13.1 Acerus Pharmaceuticals Corporation Information
11.13.2 Acerus Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.13.3 Acerus Pharmaceuticals Testosterone Replacement Therapy Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.13.4 Acerus Pharmaceuticals Testosterone Replacement Therapy Products and Services
11.13.5 Acerus Pharmaceuticals SWOT Analysis
11.13.6 Acerus Pharmaceuticals Recent Developments
12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Testosterone Replacement Therapy Sales Channels
12.2.2 Testosterone Replacement Therapy Distributors
12.3 Testosterone Replacement Therapy Customers
13 Estimates and Projections by Regions (2021-2026)
13.1 Global Testosterone Replacement Therapy Sales Forecast (2021-2026)
13.1.1 Global Testosterone Replacement Therapy Sales Forecast by Regions (2021-2026)
13.1.2 Global Testosterone Replacement Therapy Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Testosterone Replacement Therapy Sales Forecast (2021-2026)
13.2.2 North America Testosterone Replacement Therapy Revenue Forecast (2021-2026)
13.2.3 North America Testosterone Replacement Therapy Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Testosterone Replacement Therapy Sales Forecast (2021-2026)
13.3.2 Europe Testosterone Replacement Therapy Revenue Forecast (2021-2026)
13.3.3 Europe Testosterone Replacement Therapy Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Testosterone Replacement Therapy Sales Forecast (2021-2026)
13.4.2 Asia Pacific Testosterone Replacement Therapy Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Testosterone Replacement Therapy Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Testosterone Replacement Therapy Sales Forecast (2021-2026)
13.5.2 Latin America Testosterone Replacement Therapy Revenue Forecast (2021-2026)
13.5.3 Latin America Testosterone Replacement Therapy Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Testosterone Replacement Therapy Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Testosterone Replacement Therapy Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Testosterone Replacement Therapy Size Forecast by County (2021-2026)
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
【掲載企業】
AbbVie、Endo International、Eli lilly、Pfizer、Actavis (Allergan)、Bayer、Novartis、Teva、Mylan、Upsher-Smith、Ferring Pharmaceuticals、Kyowa Kirin、Acerus Pharmaceuticals
【免責事項】
https://www.globalresearch.jp/disclaimer